Alexander Seifalian, Professor of Nanotechnology and Regenerative Medicine worked at the Royal Free Hospital and University College London for over 26 years, during this time he spent a period of time at Harvard Medical School looking at caused of cardiovascular diseases and a year at Johns Hopkins Medical School looking at treatment of liver. He published more than 647 peer-reviewed research papers, and registered 14 UK and International patents. He is currently CEO of NanoRegMed Ltd, working on the commercialisation of his research. During his career Prof Seifalian has led and managed many large projects with successful outcomes in terms of commercialisation and translation to patients. In 2007 he was awarded the top prize in the field for the development of nanomaterials and technologies for cardiovascular implants by Medical Future Innovation, and in 2009 he received a Business Innovation Award from UK Trade & Investment (UKTI). He was the European Life Science Awardsâ€™ Winner of Most Innovative New Product 2012 for the â€œsynthetic tracheaâ€. Prof Seifalian won the Nanosmat Prize in 2013 and in 2016 he received the Distinguish Research Award in recognition of his outstanding work in regenerative medicine from Heals Healthy Life Extension Society. His achievements include development of the world first synthetic trachea, lacrimal drainage conduit, and vascular bypass graft using nanocomposite materials, bioactive molecules and stem cell technology. He has over 15,000 media report from his achievement, include BBC, ITV, WSJ, CNN, and many more.
Alexander Seifalian(Research Area)
Currently he is working on development and commercialisation of human organs using graphene based nanocomposite materials and stem cells technology.
Dr. Alex Savtchenko is Chief Scientific Officer at Nanotools Biosciences. He received his MS in Physics and Chemistry from the Moscow Institute of Physics and Technology (Soviet Union), and his PhD in Biological Sciences from Bogomoletz Institute of Physiology (Ukraine). Dr. Savtchenko has 15 patents and published more than 30 papers in high-profile peer-reviewed journals (e.g., Nature, Stem Cell Reports, PNAS). While working in academia (University of Miami, Stanford University) and industry (Life Technologies, Amgen), Dr. Savtchenko acquired advanced expertise in automated patch clamp electrophysiology, ion channel biophysics, high content imaging, development of fluorescent biosensors, drug discovery, and bioengineering.
Alex Savtchenko(Research Area)
A PHP Error was encountered
Message: Unknown: Failed to write session data (user). Please verify that the current setting of session.save_path is correct (/var/lib/php/sessions)